Genome Editing in Human iPS Cells to Study and Cure Disease

Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More


2020. 10. 24. The 47th Annual Meeting of Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition(Online Educational Seminar)

2020. 11. 5. Institutional Seminar by Sadao Ota from RCAST, the University of Tokyo

2020. 11. 19. Seminar for Toyama High School Students